Pharmaceutical Industry Information Portal

HomeManufacturers News

Manufacturers News

COVID-19 pathogenetic treatment is approved as an additional indication for olokizumab

Approval for a new indication will help healthcare professionals make streamlined decisions to administer preemptive anticytokine therapy.

Russia’s First Covid-19 Express Test Receives EU Certification

The company is planning deliveries to the EU in the near future, where the market in volume terms amounts to hundreds of millions of tests per month.

NANOLEK will invest 5 billion rubles in the full production cycle

Nanolek, a biopharmaceutical company, announces a plan to invest 5 billion rubles over 3 years in its full-cycle vaccine production facility in the Kirov region and an R&D Center for Biotech Medicines in Moscow.

Global Biopharmaceutical Industry is on track to produce at least 10 billion doses of COVID-19 vaccine by end 2021

Biopharmaceutical industry welcomes COVID-19 vaccine-sharing pledges but warn challenges remain to urgently address vaccine inequity

Leading infectious disease experts in Russia recognized the efficacy of Avifavir

Professor A.V. Devyatkin noted the efficacy of Avifavir® in the combined treatment of patients with COVID-19.

Creating a site for heart disease drug production on the basis of Pharmasyntez-Tyumen

The plant is actively expanding its portfolio and introducing new production facilities. Bilateral cooperation between government and business will continue in the future.
spot_img

Expert Articles

spot_img